| __timestamp | Dynavax Technologies Corporation | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 13774000 |
| Thursday, January 1, 2015 | 22180000 | 22479000 |
| Friday, January 1, 2016 | 37257000 | 27388000 |
| Sunday, January 1, 2017 | 27367000 | 35610000 |
| Monday, January 1, 2018 | 64770000 | 49007000 |
| Tuesday, January 1, 2019 | 74986000 | 61139000 |
| Wednesday, January 1, 2020 | 79256000 | 68836000 |
| Friday, January 1, 2021 | 100156000 | 97592000 |
| Saturday, January 1, 2022 | 131408000 | 106903000 |
| Sunday, January 1, 2023 | 152946000 | 120998000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology, understanding financial trends is crucial. Over the past decade, from 2014 to 2023, Vericel Corporation and Dynavax Technologies Corporation have shown significant shifts in their Selling, General, and Administrative (SG&A) expenses. Dynavax, with a 760% increase, saw its SG&A costs rise from approximately $18 million in 2014 to $153 million in 2023. Meanwhile, Vericel's expenses grew by 780%, from $14 million to $121 million in the same period.
These trends highlight the dynamic nature of the biotech sector, where strategic investments in administration and sales are pivotal for growth and innovation.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Novartis AG and Vericel Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: argenx SE vs Vericel Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Blueprint Medicines Corporation and Dynavax Technologies Corporation
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Ultragenyx Pharmaceutical Inc. and Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Vericel Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends